Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women - Contacts and Locations

Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women

This study is currently recruiting participants.

Study NCT00004400. Last updated on June 23, 2005. Information provided by FDA Office of Orphan Products Development

Please refer to this study by its ClinicalTrials.gov identifier: NCT00004400

Locations


United States, California
	Charles R. Drew University of Medicine and Science	Recruiting
	Los Angeles, California, United States, 90059
	Contact: Shalender Bhasin 213-563-9353
	Los Angeles County Harbor-UCLA Medical Center	Recruiting
	Torrance, California, United States, 90509
	Contact: G. Beall 310-222-2444

United States, Missouri
	Washington University School of Medicine	Recruiting
	Saint Louis, Missouri, United States, 63110
	Contact: K. Yarashaski 314-362-9700

Sponsors and Collaborators

FDA Office of Orphan Products Development

Charles Drew University of Medicine and Science

Investigators


Study Chair:	Shalender Bhasin	Charles Drew University of Medicine and Science